Bold claim: Isotretinoin really works for acne, but more than half of users may face psychological side effects during treatment. This Syrian study delves into both the efficacy and the mental health considerations of isotretinoin in a real-world, low-resource setting.
Overview
Acne vulgaris remains a common dermatological issue, especially among young adults, often leading to the use of powerful systemic therapies like isotretinoin. While its effectiveness for moderate to severe cases is well established, it can bring a range of adverse effects, including physical and psychological ones. A recent cross-sectional study from Syria provides important insights into these aspects in a real-life context.
Methods and Materials
Barakat and colleagues evaluated isotretinoin’s effectiveness and adverse effects in 377 participants across Syria. The group was predominantly young women aged 21–25, reflecting the demographic most affected by acne and its psychosocial impact. Most had moderate to severe acne, and a large majority (89.1%) had used isotretinoin before or were currently using it.
The researchers aimed to answer:
- How effective is isotretinoin in treating acne?
- What physical and psychological adverse effects are observed during treatment?
A questionnaire—developed with expert input—collected data on demographics, acne severity, treatment duration, adherence, and adverse effects, including mental health symptoms.
Key Findings: Effectiveness
Findings align with long-standing clinical experience: isotretinoin is highly effective for acne control. About 93.9% of participants reported overall improvement, with 74.5% describing the improvement as substantial. Adherence emerged as a critical factor in this success: patients obtaining treatment through dermatologists showed higher adherence than those using internet sources or non-medical channels (p < 0.001). This highlights the value of professional medical supervision for achieving optimal outcomes.
Adverse Effects: Physical and Psychological
Physical side effects—dry skin, cracked lips, and irritation of mucous membranes—are well known. This study makes a notable contribution by zooming in on psychological tolls, reporting that 56.3% of participants experienced psychological symptoms such as anxiety, mood swings, depression, or even suicidal thoughts. The authors caution that while physical and psychological adverse effects are clinically important, several study limitations must be acknowledged, yet the combined impact remains noteworthy.
The high rate of psychological symptoms underscores the need for mental health monitoring during isotretinoin therapy. The authors argue that psychological concerns among patients receiving isotretinoin are frequently underrecognized and not adequately addressed in routine care, echoing broader clinical observations that mental health screening should be integrated into acne management.
Implications for Practice
The study advocates a holistic, patient-centered approach to isotretinoin therapy. Integrating standardized psychological assessments (for mood, depression, and quality of life) with dermatological evaluations can help detect adverse mental health effects early and improve outcomes. The authors state that routine follow-ups should include these mental health checks to identify subtle mood or behavioral changes promptly.
Education and supervision are also crucial. Knowing the potential risks ahead of time enhances patient understanding of the drug and its symptoms. Patients treated under dermatologist supervision demonstrated notably better adherence than those who pursued over-the-counter options or non-medical avenues. These findings support targeted patient education, especially in environments where access to medical oversight is limited.
Limitations and Future Directions
As a cross-sectional study, causation cannot be established, and self-reported data may introduce biases. The sample’s predominance of young women may limit generalizability. Nonetheless, the study offers valuable perspective from a low-resource setting and highlights global gaps in awareness and management of isotretinoin’s risks.
Conclusion
This Syrian study adds to the growing body of evidence confirming isotretinoin’s effectiveness in acne treatment while emphasizing the necessity of vigilantly monitoring psychological effects. The authors conclude that physical and psychological adverse effects warrant careful, integrated monitoring, and that mental health assessments should be part of routine acne care. Ultimately, safe and effective acne management relies on addressing both skin health and overall well-being through a multidisciplinary, informed approach.
References
1. Rajput I, Anjankar VP. Side effects of treating acne vulgaris with isotretinoin: A systematic review. Cureus. 2024;16(3):e55946.
2. Barakat A, Merai R, Alhaboul A, Murad M, Barguil S. Efficacy, psychological and physical adverse effects of isotretinoin in the treatment of acne: a cross-sectional study from Syria. Sci Rep. 2025; doi:10.1038/s41598-025-30499-z
Newsletter
Enjoyed this breakdown? Subscribe to Dermatology Times for weekly insights on therapies, innovations, and real-world practice tips.
